Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cachexia × clazakizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomatitis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1 Cachexia 1

Interventions

Megestrol Acetate 4 Mirtazapine 2 ostarine 1 nabiximols 1 clazakizumab 1 anamorelin 1 Sodium Chloride 1 Physical Therapy Modalities 1 Omacor 1 Olanzapine 1 Nutrition Assessment 1 Megestrol 1 Infliximab 1 Ibuprofen 1 Gemcitabine 1 Flurandrenolone 1 Cyproheptadine 1 Clarithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CSL Behring

Phase 2 Completed

Cachexia, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡